In addition, the intravitreal injection of an miR-21 inhibitor ameliorated inflammation and reduced microvascular damage in the retina of leptin receptor-deficient (db/db) mice which are used as a genetic model of Type 2 diabetes [18]. The gene discussed is LEPR; the disease is type 2 diabetes mellitus.